Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus	Not yet recruiting	Phase 3	2026-10-08		NCT07866066

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Amgen	180

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials